News Related to triglycerides

Related coverage linked through entity extraction aliases.

CRISPR Therapeutics Positioned for Growth as Casgevy Sales Rise

Feb 20, 2026

Switzerland-based CRISPR Therapeutics stands to benefit from increased Casgevy sales following partner Vertex Pharmaceuticals' fourth-quarter results, with five additional gene-editing therapies in clinical trials targeting larger patient populations.

Eli Lilly Advances Weight-Loss Pipeline with Retatrutide Results and Orforglipron Stockpiling

Dec 12, 2025

Eli Lilly reported positive Phase 3 results for retatrutide showing up to 71.2 lbs average weight loss, while stockpiling $1.5 billion of oral drug orforglipron ahead of anticipated FDA approval in April 2026.